Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to...

por Emanuela Foglia, Paolo Bonfanti, Giuliano Rizzardini, Erminio Bonizzoni, Umberto Restelli, Elena Ricci, Emanuele Porazzi, Francesca Scolari, Davide Croce
Publicado 2013

Timing of antiretroviral therapy initiation after a first AIDS-defining event: temporal changes in clinical attitudes in the ICONA cohort.

por Antonella Cingolani, Alessandro Cozzi-Lepri, Adriana Ammassari, Cristina Mussini, Maria Alessandra Ursitti, Pietro Caramello, Gioacchino Angarano, Paolo Bonfanti, Andrea De Luca, Maria Stella Mura, Enrico Girardi, Andrea Antinori, Antonela D'Arminio Monforte, Icona Foundation Study group
Publicado 2014